Search by Drug Name or NDC

    NDC 42961-0236-02 Xpect Triple Antibiotic 400; 3.5; 5000 [iU]/g; mg/g; [iU]/g Details

    Xpect Triple Antibiotic 400; 3.5; 5000 [iU]/g; mg/g; [iU]/g

    Xpect Triple Antibiotic is a TOPICAL OINTMENT in the HUMAN OTC DRUG category. It is labeled and distributed by Cintas Corporation. The primary component is BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE.

    Product Information

    NDC 42961-0236
    Product ID 42961-236_585d3835-ac61-4081-9982-c383694ce71f
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Xpect Triple Antibiotic
    Proprietary Name Suffix n/a
    Non-Proprietary Name bacitracin zinc, neomycin sulfate, polymyxin b sulfate
    Product Type HUMAN OTC DRUG
    Dosage Form OINTMENT
    Route TOPICAL
    Active Ingredient Strength 400; 3.5; 5000
    Active Ingredient Units [iU]/g; mg/g; [iU]/g
    Substance Name BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
    Labeler Name Cintas Corporation
    Pharmaceutical Class Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part333B
    Listing Certified Through 2024-12-31

    Package

    NDC 42961-0236-02 (42961023602)

    NDC Package Code 42961-236-02
    Billing NDC 42961023602
    Package 10 PACKET in 1 BOX (42961-236-02) / .7 g in 1 PACKET (42961-236-01)
    Marketing Start Date 2023-09-13
    NDC Exclude Flag N
    Pricing Information N/A